"The book is designed to be accessible to readers with an intermediate knowledge of statistics, and can be a useful resource to statisticians, medical researchers, and regulatory personnel in drug development, as well as graduate students in the health sciences. The authors' dec…
"18" Result
Sort By:
With the critical role of statistics in the design, conduct, analysis and reporting of clinical trials or observational studies intended for regulatory purposes, numerous guidelines have been issued by regulatory authorities around the world focusing on statistical issues relate…
"The book is designed to be accessible to readers with an intermediate knowledge of statistics, and can be a useful resource to statisticians, medical researchers, and regulatory personnel in drug development, as well as graduate students in the health sciences. The authors' dec…
With the critical role of statistics in the design, conduct, analysis and reporting of clinical trials or observational studies intended for regulatory purposes, numerous guidelines have been issued by regulatory authorities around the world focusing on statistical issues relate…
This publication contains a verbatim reproduction of 21 CFR Part 50 Protection of Human Subjects, 21 CFR Part 54 Financial Disclosure by Clinical Investigators, 21 CFR Part 56 Institutional Review Boards and 21 CFR Part 312 Investigational New Drug Application.
(A) This part applies to all clinical investigations regulated by the Food and DrugAdministration under sections 505(i) and 520(g) of the Federal Food, Drug, and CosmeticAct, as well as clinical investigations that support applications for research or marketingpermits for produc…
(A) This part applies to all clinical investigations regulated by the Food and DrugAdministration under sections 505(i) and 520(g) of the Federal Food, Drug, and CosmeticAct, as well as clinical investigations that support applications for research or marketingpermits for produc…
This open access book provides an extensive review of ethical and regulatory issues related to human infection challenge studies, with a particular focus on the expansion of this type of research into endemic settings and/or low- and middle-income countries (LMICs). Human challe…